Michael Collins, MD

Michael P. Collins, MD

Associate Professor of Neurology and Pathology; Associate Director, Neuromuscular Pathology Laboratory; Director, MDA Clinic

Locations

Medical College of Wisconsin
Department of Neurology
Department of Pathology

Contact Information

(414) 955-6688

Biography

Internship, Internal Medicine, Wilford Hall Medical Center (AETC), Lackland AFB, TX, 1986-1987
Residency, Neurology, Wilford Hall Medical Center (AETC), Lackland AFB, TX, 1987-1990
Fellowship, Neuromuscular Diseases & Pathology, EMG, Ohio State University Medical Center, Columbus, 1995-1996

Education

MD, University of South Dakota School of Medicine, Sioux Falls, SD, 1986

Research Interests

Dr. Michael P. Collins is an Associate Professor in the Department of Neurology. He has considerable experience and subspecialty training in the clinical, electrodiagnostic and pathologic diagnosis of neuromuscular diseases. He is skilled in the performance of EMGs and interpretation of nerve and muscle biopsies. His clinical and research focus is inflammatory neuromuscular disorders.

Specialty and Subspecialties

Adult Neurology
Myasthenia Gravis
Neuromuscular Disease
Neuromuscular Pathology
Electromyography (EMG)
Inflammatory Neuropathies
Inflammatory Myopathies

Vasculitic neuropathies.

(Gwathmey KG, Burns TM, Collins MP, Dyck PJ.) Lancet Neurol. 2014 Jan;13(1):67-82.
Hearing aid effectiveness after aural rehabilitation: individual versus group trial results.

(Collins MP, Liu CF, Taylor L, Souza PE, Yueh B.) J Rehabil Res Dev. 2013;50(4):585-98.
The neuropathies of vasculitis.

(Collins MP, Arnold WD, Kissel JT.) Neurol Clin. 2013 May;31(2):557-95.
The vasculitic neuropathies: an update.

(Collins MP.) Curr Opin Neurol. 2012 Oct;25(5):573-85.
Mitochondrial myopathy due to novel missense mutation in the cytochrome c oxidase 1 gene.

(Massie R, Wang J, Chen LC, Zhang VW, Collins MP, Wong LJ, Milone M.) J Neurol Sci. 2012 Aug 15;319(1-2):158-63.
Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.

(Suppiah R, Hadden RD, Batra R, Arden NK, Collins MP, Guillevin L, Jayne DR, Luqmani RA, European Vasculitis Study Group.) Rheumatology (Oxford). 2011 Dec;50(12):2214-22.
Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary.

(Collins MP, Dyck PJ, Gronseth GS, Guillevin L, Hadden RD, Heuss D, Léger JM, Notermans NC, Pollard JD, Said G, Sobue G, Vrancken AF, Kissel JT, Peripheral Nerve Society.) J Peripher Nerv Syst. 2010 Sep;15(3):176-84.
Direct immunofluoresence in vasculitic neuropathy: specificity of vascular immune deposits.

(Collins MP, Periquet-Collins I, Sahenk Z, Kissel JT.) Muscle Nerve. 2010 Jul;42(1):62-9.
The additional yield of combined nerve/muscle biopsy in vasculitic neuropathy.

(Vrancken AF, Gathier CS, Cats EA, Notermans NC, Collins MP.) Eur J Neurol. 2011 Jan;18(1):49-58.
Nonsystemic vasculitic neuropathy: update on diagnosis, classification, pathogenesis, and treatment.

(Collins MP, Periquet-Collins I.) Front Neurol Neurosci. 2009;26:26-66.
Isolated vasculitis of the peripheral nervous system.

(Collins MP, Periquet MI.) Clin Exp Rheumatol. 2008 May-Jun;26(3 Suppl 49):S118-30.
Antineutrophil cytoplasmic antibodies in nonsystemic vasculitic neuropathy.

(Collins MP.) J Rheumatol. 2007 Apr;34(4):899-900.